SCHEMBL6804200

SCHEMBL6804200

COC(=O)c1ccc(CN(C)C)cc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 1/20 0.49
CFTR P13569 1/20 0.48
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
KDM4E B2RXH2 1/20 0.44
MAPK8 P45983 1/20 0.44
MAPK10 P53779 1/20 0.44
BDKRB1 P46663 1/20 0.40
CETP P11597 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
TACR1 P25103 1/20 0.40
MTTP P55157 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6799548 0.88 CFTR (0.50) CFTRPSEN1PSEN2APH1BNCSTN
SCHEMBL6805059 0.86 PSEN1 (0.52) LSSPSEN1PSEN2APH1BNCSTN
SCHEMBL23354519 0.83 CFTR (0.63) CFTRKDM4ESLC6A4SLC6A3BACE1
SCHEMBL6808895 0.82 CFTR (0.47) CFTRPSEN1PSEN2APH1BNCSTN
SCHEMBL6803026 0.81 CFTR (0.51) CFTRKDM4ESLC6A4SLC6A3BACE1
SCHEMBL2138612 0.79 CFTR (0.55) CFTRKDM4ESLC6A4SLC6A3BACE1
SCHEMBL6698582 0.79 CFTR (0.55) CFTRKDM4ESLC6A4SLC6A3MTTP
SCHEMBL23354287 0.79 SLC6A3 (0.56) CFTRKDM4ESLC6A4SLC6A3BACE1
SCHEMBL6701426 0.78 KDM4E (0.58) CFTRKDM4ESLC6A4SLC6A3BACE1
SCHEMBL23354056 0.77 CFTR (0.52) CFTRKDM4ESLC6A4SLC6A3BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 LSS 1798/4885CFTR 1213/4885PSEN1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.